Showing posts with label GlaxoSmithKline. Show all posts
Showing posts with label GlaxoSmithKline. Show all posts

Friday, May 23, 2014

Robert Ingram Recives TBJ Lifetime Achievement Award for Glaxo Work

Robert Ingram, former CEO of GlaxoWellcome (now GlaxoSmithKline), is 2014 Triangle Business Journal Life Sciences lifetime achievement award recipient.

Thursday, December 5, 2013

GSK Awards $160,000 to Durham Nonprofits

GlaxoSmithKline awarded $40,000 each to four Durham nonprofit organizations Wednesday for their work toward improving public health. The Association for the Preservation of the Eno River Valley Inc., receoved funding for protecting the river basin’s nature, culture and history; Inter-Faith Food Shuttle, was awarded for combating hunger; Kidznotes, Inc. was awarded, for providing classical music training for underprivileged children; and Student U was given a grant for promoting healthy lifestyles through education-based programs.

Friday, September 20, 2013

GlaxoSmithKline Receives Anthrax Treatment Contract

 British drugmaker GlaxoSmithKline announced Thursday that it has landed a four-year contract to supply an anthrax treatment to the U.S. government for use as a counter measure to a potential bioterrorist attack.

Tuesday, August 6, 2013

FDA OKs Glaxo Flu Vaccine

British drug maker GlaxoSmithKline which has its North American headquarters in Durham, just received FDA approval to start shipping its Fluarix Quadrivalent vaccine to CDC distribution centers and U.S. health care provider

Thursday, May 30, 2013

Two GlaxoSmithKline Drugs Approved by FDA

Two new GlaxoSmithKline drugs to treat advanced skin cancer, Tafinlar (dabrafenib) and Mekinist (trametinib), were granted Food and Drug Administration approval on Tuesday. GSK's national headquarters are located in Durham in Research Triangle Park.

Friday, January 13, 2012

Bill Shore to Retire from GSK After 27 Years

GlaxoSmithKline's community ambassador, Bill Shore, will retire from the company after 27 years of service. Shore, a Durham native, was integral to the development of GSK's community relations. Two key areas Shore especially strove to impact were education and work force development. In 2010, GSK gave $5.2 million in the Triangle and $345 million worldwide.

Wednesday, June 29, 2011

Senior PharmAssist Honors GlaxoSmithKline with Community Health Citizenship Award

Durham-based Senior PharmAssist celebrated its 17th anniversary by announcing an initiative to partner with more corporations in Research Triangle Park and Durham by honoring GlaxoSmithKline with the inaugural Community Health Citizenship Award.